Lucid Diagnostics Geçmiş Kazanç Performansı
Geçmiş kriter kontrolleri 0/6
Lucid Diagnostics's earnings have been declining at an average annual rate of -41.5%, while the Medical Equipment industry saw earnings growing at 12.9% annually. Revenues have been growing at an average rate of 75.6% per year.
Anahtar bilgiler
-41.5%
Kazanç büyüme oranı
-21.3%
EPS büyüme oranı
| Medical Equipment Sektör Büyümesi | 8.9% |
| Gelir büyüme oranı | 75.6% |
| Özkaynak getirisi | -292.0% |
| Net Marj | -1,425.0% |
| Sonraki Kazanç Güncellemesi | 13 Nov 2024 |
Yakın geçmiş performans güncellemeleri
Güncelleme yok
Recent updates
We're A Little Worried About Lucid Diagnostics' (NASDAQ:LUCD) Cash Burn Rate
May 09
Lucid Diagnostics (NASDAQ:LUCD) Will Have To Spend Its Cash Wisely
Dec 15Lucid Diagnostics launches stage II lucid test center in California, Texas, Florida, and Ohio
Aug 11We're Keeping An Eye On Lucid Diagnostics' (NASDAQ:LUCD) Cash Burn Rate
Jul 07Gelir ve Gider Dağılımı
Lucid Diagnostics nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.
Kazanç ve Gelir Geçmişi
| Tarih | Gelir | Kazançlar | G+A Giderleri | Ar-Ge Giderleri |
|---|---|---|---|---|
| 30 Jun 24 | 4 | -54 | 34 | 6 |
| 31 Mar 24 | 3 | -55 | 33 | 7 |
| 31 Dec 23 | 2 | -53 | 36 | 7 |
| 30 Sep 23 | 2 | -57 | 38 | 8 |
| 30 Jun 23 | 1 | -57 | 39 | 9 |
| 31 Mar 23 | 1 | -60 | 42 | 10 |
| 31 Dec 22 | 0 | -56 | 40 | 11 |
| 30 Sep 22 | 1 | -53 | 37 | 12 |
| 30 Jun 22 | 1 | -45 | 32 | 12 |
| 31 Mar 22 | 1 | -37 | 25 | 10 |
| 31 Dec 21 | 1 | -28 | 18 | 9 |
| 30 Sep 21 | 0 | -20 | 11 | 8 |
| 30 Jun 21 | 0 | -15 | 8 | 7 |
| 31 Mar 21 | 0 | -10 | 4 | 6 |
| 31 Dec 20 | 0 | -8 | 3 | 5 |
| 30 Sep 20 | 0 | -7 | 2 | 5 |
| 31 Dec 19 | 0 | -4 | 1 | 3 |
| 30 Sep 19 | 0 | -4 | 2 | 2 |
Kaliteli Kazançlar: LUCD is currently unprofitable.
Büyüyen Kar Marjı: LUCD is currently unprofitable.
Serbest Nakit Akışı ve Kazanç Analizi
Geçmiş Kazanç Büyüme Analizi
Kazanç Eğilimi: LUCD is unprofitable, and losses have increased over the past 5 years at a rate of 41.5% per year.
Büyüme Hızlandırma: Unable to compare LUCD's earnings growth over the past year to its 5-year average as it is currently unprofitable
Kazançlar vs. Sektör: LUCD is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (11.7%).
Özkaynak Getirisi
Yüksek ROE: LUCD has a negative Return on Equity (-291.98%), as it is currently unprofitable.